RACHEL MAGEE: Open Payments
NPI 1689243669 · JONESBORO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$887 in 40 payments from 13 companies in 2025. Trend: 2023 $464 · 2024 $409 · 2025 $887
Food & beverage: $797Education: $90
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 13 | $298 |
| Novo Nordisk Inc | 6 | $173 |
| Sage Therapeutics, LLC | 6 | $121 |
| Hologic Sales and Service, LLC | 3 | $71 |
| Lilly USA, LLC | 3 | $54 |
| SHIELD THERAPEUTICS INC | 2 | $38 |
| Dexcom, Inc. | 1 | $38 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Exeltis, USA Inc. | 1 | $17 |
Products named: Veozah, Wegovy, ZURZUVAE, ZEPBOUND, MYOSURE TISSUE REMOVAL DEVICE, ACCRUFER, Dexcom G6 Transmitter, Cresemba.
Industry payments across LA — which companies pay providers there.
